Video

Avik Roy Discusses King v. Burwell and Potential Disruption

Leading up to the Supreme Court's decision in the case of King v. Burwell, Avik Roy, senior fellow at the Manhattan Institute, discusses in what ways Congress should potentially act if the plaintiffs receive a favorable ruling, who is to blame more if subsidies are removed from the federal marketplace, and how much time there will be for a patch to prevent millions of Americans losing financial assistance and subsequently their health insurance.

Leading up to the Supreme Court's decision in the case of King v. Burwell, Avik Roy, senior fellow at the Manhattan Institute, discusses in what ways Congress should potentially act if the plaintiffs receive a favorable ruling, who is to blame more if subsidies are removed from the federal marketplace, and how much time there will be for a patch to prevent millions of Americans losing financial assistance and subsequently their health insurance.

Mr Roy lays the blame for the negative effects that will ensue should the Supreme Court rule in favor of the plaintiffs on both the Obama administration and the Republicans. The adminisrtation is at fault for even creating the situation in the first place, but since Republicans now control Congress, if they do nothing they will be responsible for the outcome.

"So the question is, 'Can Republicans agree on how to [minimize the disruption]?'" he explained. "Because there are different schools of thought. Some conservatives say, 'Don't do anything. Let the disruption happen, it's not our fault.' Others say, 'Well, listen we control the legislative branch, it's up to us to try to come up with a way to handle this problem.'"

Related Videos
Kenny Cole, MD
Richard Lafayette, MD, FACP, Stanford University Medical Center
Craig A. Portell, MD, UVA Health
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Dr Johnie Rose
Andrew Kuykendall, MD
Joseph Saseen, PharmD
Bridgette Picou, LVN, ACLPN, The Well Project
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo